Multigram-Scale Synthesis of Luminescent Cesium Lead Halide Perovskite Nanobricks for Plastic Scintillators
Source abstract
Abstract
High Resolution Image Download MS PowerPoint Slide Cesium lead halide perovskite nanocrystals of general formula CsPbX 3 are having tremendous impact on a vast array of technologies requiring strong and tunable luminescence across the visible range and solutions processing. The development of plastic scintillators is just one of the many relevant applications. The syntheses are relatively simple but generally unsuitable to produce a large amount of material of reproducible quality required when moving from proof-of-concept scale to industrial applications. Wastes, particularly large amounts of lead-contaminated toxic and flammable organic solvents, are also an open issue. We describe a simple and reproducible procedure enabling the synthesis of luminescent CsPbX 3 nanobricks of constant quality on a scale going from 0.12 to 8 g in a single batch. We also show complete recycling of the reaction wastes, leading to dramatically improved efficiency and sustainability.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Perovskite Materials and Applications · Luminescence Properties of Advanced Materials · Quantum Dots Synthesis And Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Materials Science, University of Milano-Bicocca, via R. Cozzi 55, I-20126 Milan, Italy
IMEM-CNR Institute, Parco Area delle Scienze 37/A, 43124 Parma, Italy
Funding
European Commission · Ministero dell'Universit? e della Ricerca
References (43)
Show source-provided references
1. 10.1021/acsnano.0c0890310.1021/acsnano.0c08903 ↗
2. 10.1038/s41563-018-0018-410.1038/s41563-018-0018-4 ↗
3. 10.1021/acs.chemrev.8b0064410.1021/acs.chemrev.8b00644 ↗
4. 10.1038/am.2016.16710.1038/am.2016.167 ↗
5. 10.1016/j.matlet.2018.02.08910.1016/j.matlet.2018.02.089 ↗
6. 10.1002/aenm.20150245810.1002/aenm.201502458 ↗
7. 10.1039/D2NR01292H10.1039/D2NR01292H ↗
8. 10.1039/C5CC08643D10.1039/C5CC08643D ↗
9. 10.1038/s41565-020-0683-810.1038/s41565-020-0683-8 ↗
10. 10.1038/nmat427110.1038/nmat4271 ↗
11. 10.1021/acs.accounts.9b0038210.1021/acs.accounts.9b00382 ↗
12. 10.1021/acs.jpclett.9b0305710.1021/acs.jpclett.9b03057 ↗
13. 10.1038/s41560-018-0313-y10.1038/s41560-018-0313-y ↗
14. 10.1016/j.nanoen.2017.05.03010.1016/j.nanoen.2017.05.030 ↗
15. 10.1021/acsenergylett.7b0070110.1021/acsenergylett.7b00701 ↗
16. 10.1021/nl504877910.1021/nl5048779 ↗
17. 10.1021/acs.nanolett.8b0359810.1021/acs.nanolett.8b03598 ↗
18. 10.1021/jacs.6b0316610.1021/jacs.6b03166 ↗
19. 10.1021/jacs.5b1212410.1021/jacs.5b12124 ↗
20. 10.1021/jacs.5b0540410.1021/jacs.5b05404 ↗
21. 10.1002/adfm.20160010910.1002/adfm.201600109 ↗
22. 10.1021/acsnano.5b0115410.1021/acsnano.5b01154 ↗
23. Montaguti P. · Arzneimittelforschung. · 1994 · 44 · 566
24. 10.1002/adfm.20170600010.1002/adfm.201706000 ↗
25. 10.1039/C6CC01500J10.1039/C6CC01500J ↗
26. 10.1021/acsnano.5b0819310.1021/acsnano.5b08193 ↗
27. 10.1021/acs.chemmater.7b0416110.1021/acs.chemmater.7b04161 ↗
28. 10.1021/acs.chemmater.8b0329810.1021/acs.chemmater.8b03298 ↗
29. 10.1002/chem.20170568210.1002/chem.201705682 ↗
30. 10.1021/acs.jpclett.7b0043110.1021/acs.jpclett.7b00431 ↗
31. 10.1038/nenergy.2016.19410.1038/nenergy.2016.194 ↗
32. 10.1002/smtd.20180048910.1002/smtd.201800489 ↗
33. 10.1021/acs.chemmater.7b0283410.1021/acs.chemmater.7b02834 ↗
34. 10.1039/C9SE00502A10.1039/C9SE00502A ↗
35. 10.1016/j.nanoen.2020.10446710.1016/j.nanoen.2020.104467 ↗
36. 10.12688/openreseurope.13428.210.12688/openreseurope.13428.2 ↗
37. 10.1021/acs.oprd.0c0028510.1021/acs.oprd.0c00285 ↗
38. 10.1039/D0CP06245F10.1039/D0CP06245F ↗
39. 10.1007/s12274-019-2371-210.1007/s12274-019-2371-2 ↗
40. 10.1021/acsnano.7b0835710.1021/acsnano.7b08357 ↗
41. 10.1039/C7TC02194A10.1039/C7TC02194A ↗
42. 10.1021/acsnano.5b0629510.1021/acsnano.5b06295 ↗
43. 10.1016/j.chempr.2019.01.00710.1016/j.chempr.2019.01.007 ↗